<DOC>
	<DOCNO>NCT01249196</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety SK-PC-B70M patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Confirmatory Trial SK-PC-B70M Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Clinical diagnosis probable Alzheimer 's disease ( DSMIV NINCDSADRDA criterion ) MRI within last 12 month consistent diagnosis AD MMSE score 10 26 CDR 1 2 AChEI memantine take least 3 month prior screen Other central nervous disease Hypothyroidism , Vitamin B12/ Folic acid deficiency , Hypercalcemia , Neurosyphilis , AIDS T.I.A Major infarction within last 12 month Any serious disorder could limit ability patient participate study COPD asthma Any condition would make patient caregiver , opinion investigator , unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>